An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Several professionals said the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also found groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.
Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, messages display dark colored packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service stated it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.
